Stay updated on Upadacitinib in Active Ankylosing Spondylitis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page.

Latest updates to the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page
- Check2 days agoChange DetectedA new related publication (on CD8+ T cells in ankylosing spondylitis) is added to the study’s publications list. The site’s displayed release/version label is updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check9 days agoChange DetectedAdded Revision: v3.5.2. Deleted Revision: v3.5.0.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedAdded a new publication reference: 'Impact of Upadacitinib on Reducing Pain in Patients Across the Axial Spondyloarthritis Spectrum: A Post Hoc Analysis' (Rheumatol Ther. 2026). Updated revision to v3.5.0 (from v3.4.3).SummaryDifference0.1%

- Check52 days agoChange DetectedThe page's revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 in the page footer. No changes to study details, eligibility criteria, locations, or outcomes.SummaryDifference0.0%

- Check81 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0 on the page, a minor UI/version-tracking update with no changes to study content.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib in Active Ankylosing Spondylitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page.